SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-21-001965
Filing Date
2021-03-22
Accepted
2021-03-22 16:30:46
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031521p.htm 10-K 953514
2 EXHIBIT 21.01 exh_2101.htm EX-21.01 1455
3 EXHIBIT 23.01 exh_2301.htm EX-23.01 2031
4 EXHIBIT 31.1 exh_311.htm EX-31.1 7047
5 EXHIBIT 31.2 exh_312.htm EX-31.2 6834
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3275
7 EXHIBIT 32.2 exh_322.htm EX-32.2 3216
14 GRAPHIC clinicprog.jpg GRAPHIC 28425
  Complete submission text file 0001171843-21-001965.txt   4782832

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE snca-20201231.xml EX-101.INS 687967
9 XBRL SCHEMA FILE snca-20201231.xsd EX-101.SCH 62927
10 XBRL CALCULATION FILE snca-20201231_cal.xml EX-101.CAL 52280
11 XBRL DEFINITION FILE snca-20201231_def.xml EX-101.DEF 403714
12 XBRL LABEL FILE snca-20201231_lab.xml EX-101.LAB 391087
13 XBRL PRESENTATION FILE snca-20201231_pre.xml EX-101.PRE 435742
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33672 | Film No.: 21761680
SIC: 2836 Biological Products, (No Diagnostic Substances)